Several genetic polymorphisms in genes such as cytochrome-P450 (CYP)2C8 and CYP2C9, may influence survival after cancer diagnosis due to their role in the metabolism of various breast cancer drugs, including tamoxifen and chemotherapy (Jin et al, 2005). Here, CYP2C8 is linked to cancer.